Lundbeck has halted studies in Russia, continues to supply medicine
Like many other pharmaceutical firms recently, Lundbeck has paused its activities in Russia due to the invasion of Ukraine, but the company will still supply medicines for as long as sanctions allow.
by marketwire, translated by daniel pedersen
Pharmaceutical firm Lundbeck is watching the war in Ukraine with concern, in addition to making sure it complies with sanctions imposed on Russia due to its invasion of its neighboring country, the leadership team says at the company’s general meeting on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
